News // 8 mars 2013
Dr Robert Mamoun CEO/CSO will attend this event on 22-25th April, 2013 and will be delighted to meet you to present Ciloa’s technology that allows getting fully native and mature membrane proteins out of cells. The proteins belong to all classes: GPCRs, Kinase Receptors, Ion channels, viral proteins, Ig superfamily, etc.
This innovation helps to develop new drugs against membrane proteins receptors, therapeutic monoclonal antibodies, vaccines and in clinical diagnosis.
The applications concern all the domains of human health (cancers, cardiopathologies, diabetes, neuro-pathologies, infectious diseases...).
News // 27 février 2013
Dr Manuela Lotierzo, Scientist in charge of protein interactions in Ciloa will attend the International Society for Extracellular Vesicles on 17-20th April in Boston.
She will present the high added value brought by Ciloa technology of sorting membrane proteins on exosomes, to develop unique and powerful analysis systems in ligand-membrane protein interactions.
The ISEV was started in 2011 by the international exosomes and microvesicles community through internet interactions, and the first meeting was in Göteborg, Sweden, in April 2012. ISEV is also publishing a scientific open access journal, and is in the planning of arranging several educational activities internationally.
Dr Robert Mamoun CEO/CSO will attend BIO Spring in Barcelona on 11-13th March, 2013 and take part in the partneringONE networking in order to present the technology and products of Ciloa and to discuss about possible collaborations.
The technology allows the production of native GPCRs, Ion channels, Kinase receptors and more on exosomes.
The event enables Ciloa delegates to efficiently meet and get partnerships started with companies of all the life science value chain, such as large biotechs and pharmas.
We look forward to meeting you in Barcelona ! More
Dr Robert Mamoun CEO/CSO will attend the 6th Annual European Life Sciences CEO Forum, held on 5th-6th March 2013 at the Hilton Zurich Airport Hotel, Switzerland.
He will present Ciloa and its technology to produce native membrane and derivatives such as bio-drugs and vaccines.
This event will be highly transactional, bringing together an exciting cross-section of venture-funded and small-cap companies with leading investors, pharmas, and scientific thought leaders. Around 350 delegates are expected and 80 presenting companies. More.
News // 8 février 2013
Ciloa announced that the Company’s CEO and CSO, Dr Robert Mamoun will attend Buzz4Bio on February 13-14 in Paris. This event is dedicated to Bioproduction and its technological progress.
Let’s meet there! More
News // 29 octobre 2012
Ciloa will present its technology for producing native membrane proteins out of cells at BIO-Europe 2012, the Europe's largest partnering conference, which held at the Congress Center Hamburg, Germany (12-14 November).
His President, Robert Mamoun, will give a talk at the "Next Generation Biotech Company Presentations" (Tuesday, Nov 13, 2012 at 14:30) on the solution to produce native GPCRs, Ion channels, Kinase receptors and more on exosomes.
He will also have the pleasure to meet you at partneringONE networking.
News // 29 juin 2012
June 18th-21th, 2012
This event drew about 16 500 industry leaders from 49 states and 65 countries. Ciloa presented to pharmaceuticals and biotechnologies companies its technology for producing membrane protein on exosomes.
This technology allows producing fully native GPCRs, Ion Channel complex, Kinase Receptors and more, out of cells and allows also unlocking several bottleneck steps in the development of therapeutic monoclonal antibodies.
Presentation Flyer: Flyer Ciloa June 2012
News // 14 juin 2012
In the context of the next FP7-HEALTH proposal, a partnering event was organized to initiate contacts between SMEs and Academics. Ciloa was invited to present his innovative technology of "Native membrane receptors out of cells" that allow to develop new Vaccines & Therapeutics.
The presentation is available: Click here
News // 19 janvier 2011
Ciloa presented its unique technology for producing membrane proteins from cells at the BioEurope conference held in Munich, Germany.
Biotech companies showed keen interest in Ciloa technology for obtaining the membrane proteins of their choice to develop therapeutical products. The key appeal of the Ciloa solution is that it offers truly native GPCR on exosomal nanovesicles.
The use of Surface Plasmon Resonance (SPR) to detect interactions of chemokine and monoclonal antibodies with non-labeled GPCR represents a technological disruption that has the potential to significantly increase efficiency for biotech firms. Identifying GPCR-ligand interactions and accessing their affinity constants at the same time open the door for easier development of therapeutic ligands.
News // 17 janvier 2011
The industry is beginning to take notice of Ciloa exosome technology, notably thanks to conferences such as the first International Workshop on Exosomes (IWE) held in Paris in January 2011. This highly successful event was marked by productive exchanges and open discussions.
We would particularly like to thank the organizers of this first IWE event, Clotilde Thery and Graca Raposo from the Institut Curie in Paris, France.
IWE events will now be organized on an annual basis in order to follow-up and support the development of this scientific community. In particular, these meetings will be devoted to all types of secreted membrane vesicles. Jan Lotvall, along with Margareta Sjostrand and Annika Scheynius, have offered to organize the next IWE event in Göteborg, Sweden on April 18-21, 2012. Mark your calendar for this important scientific event.
Lawrence Rajendran has taken the initiative to create a Facebook discussion group called "Exosomes, microvesicles, and other secreted vesicles". This group is intended to serve as a platform to share information until a complete Web site dedicated to exosomes and secreted vesicles is set up. Login to Facebook and check it out!
We look forward to seeing you again or meeting you in Göteborg !